Eyes reflect our soul and health status
DOI:
https://doi.org/10.12775/HERB.2020.012Keywords
lutein, zeaxanthin, AMD, macula, carotenoids, anthocyaninsAbstract
Significant amount of studies on the role of micronutrients in ophthalmology has been published in recent years. The macular pigment carotenoids lutein and zeaxanthin are the constituents of dietary supplements dedicated for the prevention of visual loss from age-related macular degeneration (AMD) and other ocular diseases. These carotenoids increase total amount of macular pigments and thus may lower risk of AMD. Dietary supplement should contain lutein and zeaxanthin (5:1), as
well as anthocyanins (bilberry extract), vitamin C, E and zinc. At present, properly adjusted everyday diet and intake of dietary supplements are recommended to people with already progressing AMD and at an increased risk of the disease development.
References
Jankowska-Lech I. i wsp., Zwyrodnienie plamki związane z wiekiem (AMD) – choroba starzejących się społeczeństw. Postępy Nauk Medycznych, 2013, XXVI (12), s. 868–873.
Stankiewicz A., Suplementacja diety w zwyrodnieniu plamki związanym z wiekiem. Fakty, mity i zagrożenia. Część 1., Przegląd Okulistyczny, 2015, 2, s. 4–5.
Dziennik Urzędowy L 136 Unii Europejskiej, wydanie polskie, 2012, s. 55.
Age-Related Eye Disease Study Research Group, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report, No. 8, Archives of Ophthalmology, 2001, 119 (10), s. 1417–1436.
Age-Related Eye Disease Study Research Group1, SanGiovanni J.P., i wsp., The rela-tionship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study AREDS report, No. 22, Archives of Ophthalmology, 2007, 125(9), s. 1225–1232.
Lima V.C., Rosen R.B., Farah M., Macular pigment in retinal health and disease, In-ternational Journal of Retina and Vitreous, 2016, 2(19), s. 1–9.
Krinsky N.I., Landrum J.T., Bone R.A., Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye, Annual Review of Nutrition, 2003, 23, s. 171–201.
Landrum J.T., Bone R.A., Lutein, zeaxanthin and the macular pigment, Archives of Biochemistry and Biophysics, 2001, 385, s. 28–40.
Drobek-Słowik M., Karczewicz D., Safranof K., Potencjalny udział stresu oksydacyjnego w patogenezie zwyrodnienia plamki związanego z wiekiem (AMD), Postępy Higieny i Medycyny Doświadczalnej, 2007, 61, s. 28–37.
Agostoni C. i wsp., Scientific opinion on the substantiation of health claims related to lutein and protection of DNA, proteins and lipids from oxidative damage (ID 3427), protection of the skin from UV induced (including photo-oxidative) damage (ID 1605, 1779) and maintenance of normal vision (ID 1779, 2080) pursuant to Article 13(1) of Regulation (EC) No. 1924/2006, Journal of European Food Safety Authority (EFSA),
, 9, s. 2030–2046.
Agostoni C. i wsp., Scientific opinion on the substantiation of health claims related to lutein and maintenance of normal vision (ID 1603, 1604, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, Journal of European Food Safety Authority (EFSA), 2012, 10, s. 2716–2733.
Dawczynski J. i wsp., Long term e{ects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study. Graefe’s Archive for Clinical and Experimental Ophthalmology, 2013, 251(12), s. 2711–2723.
Meyer zu Westrup V., i wsp., Changes of macular pigment optical density in elderly eyes: a longitudinal analysis from the MARS study, International Journal of Retina and Vitreous, 2016, 2(14), s. 1–8.
Ma L. i wsp., Improvement of retinal function in early age-related macular degeneration a|er lutein and zeaxanth in supplementation: A randomized, double-masked, placebo-controlled trial, American Journal of Ophthalmology, 2012, 154(4), s. 625–634.[15] Ma L. i wsp., E{ect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration, Ophthalmology, 2012, 119(11),
s. 2290–2297.
Xue C., Rosen R., Jordan A., Hu D.N., Management of ocular diseases using lutein and zeaxanthin: What have we learned from experimental animal studies?, Journal of Ophthalmology, 2015, s. 1–11.
Canter, P., Ernst, E., Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision – a systematic review of placebo-controlled trials, Survey of Ophthalmology, 2004, 49(1), s. 38–50
Matsumoto, H., Nakamura Y., Tachibanaki S., Kawamura S., Hirayama M., Stimulatory e{ect of cyanidin 3-glycosides on the regeneration of rhodopsin, Journal of Agricultural and Food Chemistry, 2003, 51, s. 3560–3563.[19] Kalt W. i wsp., Identication of anthocyanins in the liver, eye, and brain of blueberry-fed pigs, Journal of Agricultural and Food Chemistry, 2008, 56, s. 705–712.
Matsumoto, H., Nakamura Y., Iida H., Ito K., Ohguro H., Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues, Experimental Eye Research, 2006, 83(2), s. 348–356.
Hamułka J., Koczara J., Gronek M., Lutein content of selected Polish foods and estimation of its intake, Polish Journal of Food and Nutrition Sciences, 2005, 14/15(2), s. 201–206.
Downloads
The publisher's shop:
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 2560
Number of citations: 0
